Beyond Next Ventures Inc., a Tokyo-based venture capital firm specializing in deep tech startups (CEO: Tsuyoshi Ito), is proud to announce a Memorandum of Understanding (MOU) for a strategic partnership with Fortrea Inc, a leading global Clinical Research Organization (CRO). This marks Fortrea’s first partnership with a Japanese venture capital firm.

As a global leader in clinical development services and patient access, Fortrea is dedicated to advancing clinical research worldwide. Through this partnership with Fortrea, Beyond Next Ventures aims to significantly bolster the international expansion of its portfolio startups in the bio-pharmaceutical sector.

World-Class Global Clinical Trial Support

Fortrea’s extensive network of scientific and clinical experts around the globe enables them to support the design and execution of complex trial designs, streamline and optimize drug development pathways, and accelerate bio-pharmaceutical time to market. This collaboration will accelerate the development of innovative medicines by our invested startups to meet global standards.

Access to Global Markets

Fortrea’s global presence and deep understanding of regional pharmaceutical regulations, approval processes, and legal frameworks, coupled with their knowledge of a wide range of therapeutic areas, will be invaluable in shaping development strategies and tailoring its development solutions to specific clinical needs in various regions.

Network with International Experts

Leveraging Fortrea’s global network of specialists and industry stakeholders will provide opportunities for business development, funding, and partnerships beyond research and development.

Comments from Andrew Hegedus, Chief Development Officer of Fortrea

”Start-ups in Japan are an extraordinary source of scientific and technological innovation. Fortrea appreciates both the unique potential in these companies and the pressures that they must overcome, to be successful in competitive global drug development markets. We bring more than 30 years of experience spanning over 20 therapeutic specialty areas, developing medicines all around the world, and we are looking forward to using this exciting partnership with Beyond Next Ventures to support start-ups, with strategic solutions and critical insights.”

Comments from Tsuyoshi Ito, CEO of Beyond Next Ventures

“From its inception, a pharmaceutical startup increases its prospects for significant fundraising and partnerships by implementing development strategies and plans aimed at global development. Through this partnership, pharmaceutical startups, even in their early stages, can more easily access Fortrea’s world-class research and development environment, knowledge of various international markets, and global network. I am confident that this will strongly support the global expansion of Japanese bio-pharmaceutical startups. We will create successful collaboration examples with our investee startups and contribute to the ecosystem of the bio-pharmaceutical field.”

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

About Beyond Next Ventures

Creating the beyond next society; enabling exceptional people solving global challenges.
We believe deep tech scientific innovations can enrich the world. Gathering top talent and risk financing together with these innovations inspires new business models and ensures future generations by creating a reinforcing cycle of science and technology innovation.
The ecosystem we are building supports researchers with resources for business planning, HR team building, shared lab space with experimental infrastructure, and of course financing. As an ecosystem builder where “exceptional challengers” in the deep tech field gather, we continue to boldly explore new frontiers.

• Head Office: 3-7-2 Nihonbashi Honcho, Chuo-ku, Tokyo, MFPR Nihonbashi Honcho Building, 3rd Floor
• Subsidairy: Galaxy-Wework, 43, Residency Road, Shanthala Nagar Ashok Nagar, Bengaluru, Karnataka, India – 560025
• Representative: President & CEO, Tsuyoshii Ito
• Established: August 2014
• Business: Investment and growth support for deep tech startups in Japan and India, support for the commercialization of research seeds, cultivation and formation of management talent and teams, operation of shared wet labs, etc.
• URL: https://beyondnextventures.com/